What is Anima?
Anima specializes in automated, always-on patient triage solutions designed to enhance the speed and efficiency of healthcare delivery. Founded in March 2021, the company addresses the critical issue of high workloads in primary care, which persists even with the adoption of telemedicine and e-consultations. Anima's technology aims to provide optimal patient care up to ten times faster than traditional methods, leveraging its founders' clinical experience to bridge the gap between patient needs and clinician capacity.
How much funding has Anima raised?
Anima has raised a total of $14.5M across 2 funding rounds:
Angel/Seed
$2.5M
Series A
$12M
Angel/Seed (2021): $2.5M with participation from Amino Collective and Hummingbird Ventures
Series A (2024): $12M led by Hummingbird Ventures, Y Combinator, and Molten
Key Investors in Anima
Hummingbird Ventures
Hummingbird Ventures is a global seed investment fund that focuses on investing in outlier founders at the earliest stages of their ventures, providing significant support throughout the lifecycle of the companies they back.
Y Combinator
Y Combinator is a renowned accelerator program that provides seed funding for startup businesses and connects them with investors.
Molten
Molten, likely referring to Draper Esprit, is a venture capital firm that invests in high-growth technology companies with global ambitions.
What's next for Anima?
The substantial enterprise-level funding and recent strategic investment signal a pivotal growth phase for Anima. This capital infusion is expected to accelerate the company's product development, expand its market reach within the UK and potentially internationally, and further enhance its automated triage platform. Anima is poised to solidify its position as a key innovator in healthtech, driving efficiency and improving patient outcomes in primary care settings.
See full Anima company page
